Literature DB >> 23324361

Perplexities of pertussis: recent global epidemiological trends and their potential causes.

D W Jackson1, Pejman Rohani1.   

Abstract

Recent much-publicized increases in pertussis case reports in some countries with high vaccine coverage have raised concerns about its current and future control. The ubiquity of this trend, however, remains unexamined. In an attempt to paint a global picture, we used case counts to determine which countries experienced statistically significant trends in incidence over the past two decades and to map changes in incidence during this period. These data reveal that pertussis resurgence is not a universal phenomenon. The heterogeneity in incidence trends, even in countries with superficially similar demography, socioeconomic conditions and vaccination programmes, is striking and requires explanation. In this opinion piece, we review and assess the multifaceted proposed explanations incorporating evolution, population dynamics, and the details of immunization programmes. While we do not solve the riddle that is pertussis epidemiology, we highlight critical aspects that are likely to hold the key to understanding its worldwide epidemiology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23324361      PMCID: PMC9151176          DOI: 10.1017/S0950268812003093

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  74 in total

1.  Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom.

Authors:  N K Fry; S Neal; T G Harrison; E Miller; R Matthews; R C George
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

2.  The decline and resurgence of pertussis in the US.

Authors:  Pejman Rohani; John M Drake
Journal:  Epidemics       Date:  2011-10-14       Impact factor: 4.396

3.  Pertussis: increasing disease as a consequence of reducing transmission.

Authors:  Ricardo Aguas; Guilherme Gonçalves; M Gabriela M Gomes
Journal:  Lancet Infect Dis       Date:  2006-02       Impact factor: 25.071

4.  Appearance of Fim3 and ptxP3-Bordetella pertussis strains, in two regions of Sweden with different vaccination programs.

Authors:  Abdolreza Advani; Lennart Gustafsson; Christina Ahrén; Frits R Mooi; Hans O Hallander
Journal:  Vaccine       Date:  2011-03-09       Impact factor: 3.641

5.  The recurrence of whooping cough: possible implications for assessment of vaccine efficacy.

Authors:  P E Fine; J A Clarkson
Journal:  Lancet       Date:  1982-03-20       Impact factor: 79.321

6.  Vaccination of infants with a four-dose and a three-dose vaccination schedule.

Authors:  J Taranger; B Trollfors; N Knutsson; V Sundh; T Lagergård; E Ostergaard
Journal:  Vaccine       Date:  1999-12-10       Impact factor: 3.641

7.  Review of the 2008-2009 pertussis epidemic in NSW: notifications and hospitalisations.

Authors:  Paula J Spokes; Helen E Quinn; Jeremy M McAnulty
Journal:  N S W Public Health Bull       Date:  2010 Jul-Aug

8.  Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management.

Authors:  Annemarie M J Wensing; David A van de Vijver; Gioacchino Angarano; Birgitta Asjö; Claudia Balotta; Enzo Boeri; Ricardo Camacho; Maire-Laure Chaix; Dominique Costagliola; Andrea De Luca; Inge Derdelinckx; Zehava Grossman; Osamah Hamouda; Angelos Hatzakis; Robert Hemmer; Andy Hoepelman; Andrzej Horban; Klaus Korn; Claudia Kücherer; Thomas Leitner; Clive Loveday; Eilidh MacRae; Irina Maljkovic; Carmen de Mendoza; Laurence Meyer; Claus Nielsen; Eline L Op de Coul; Vidar Ormaasen; Dimitris Paraskevis; Luc Perrin; Elisabeth Puchhammer-Stöckl; Lidia Ruiz; Mika Salminen; Jean-Claude Schmit; Francois Schneider; Rob Schuurman; Vincent Soriano; Grzegorz Stanczak; Maja Stanojevic; Anne-Mieke Vandamme; Kristel Van Laethem; Michela Violin; Karin Wilbe; Sabine Yerly; Maurizio Zazzi; Charles A Boucher
Journal:  J Infect Dis       Date:  2005-08-15       Impact factor: 5.226

9.  Potential impact of acceleration of the pertussis vaccine primary series for infants.

Authors:  Myrick C Shinall; Timothy R Peters; Yuwei Zhu; Qingxia Chen; Katherine A Poehling
Journal:  Pediatrics       Date:  2008-11       Impact factor: 7.124

10.  Estimating the duration of pertussis immunity using epidemiological signatures.

Authors:  Helen J Wearing; Pejman Rohani
Journal:  PLoS Pathog       Date:  2009-10-30       Impact factor: 6.823

View more
  61 in total

Review 1.  The pertussis enigma: reconciling epidemiology, immunology and evolution.

Authors:  Matthieu Domenech de Cellès; Felicia M G Magpantay; Aaron A King; Pejman Rohani
Journal:  Proc Biol Sci       Date:  2016-01-13       Impact factor: 5.349

2.  Deciphering the impacts of vaccination and immunity on pertussis epidemiology in Thailand.

Authors:  Julie C Blackwood; Derek A T Cummings; Hélène Broutin; Sopon Iamsirithaworn; Pejman Rohani
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

3.  Dynamics of Pertussis Transmission in the United States.

Authors:  F M G Magpantay; P Rohani
Journal:  Am J Epidemiol       Date:  2015-05-27       Impact factor: 4.897

4.  Epidemiological evidence for herd immunity induced by acellular pertussis vaccines.

Authors:  Matthieu Domenech de Cellès; Maria A Riolo; Felicia M G Magpantay; Pejman Rohani; Aaron A King
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-10       Impact factor: 11.205

Review 5.  Temporally Varying Relative Risks for Infectious Diseases: Implications for Infectious Disease Control.

Authors:  Edward Goldstein; Virginia E Pitzer; Justin J O'Hagan; Marc Lipsitch
Journal:  Epidemiology       Date:  2017-01       Impact factor: 4.822

6.  Transient indicators of tipping points in infectious diseases.

Authors:  Suzanne M O'Regan; Eamon B O'Dea; Pejman Rohani; John M Drake
Journal:  J R Soc Interface       Date:  2020-09-16       Impact factor: 4.118

7.  Acellular Pertussis Vaccine Effectiveness Over Time.

Authors:  Ousseny Zerbo; Joan Bartlett; Kristin Goddard; Bruce Fireman; Edwin Lewis; Nicola P Klein
Journal:  Pediatrics       Date:  2019-06-10       Impact factor: 7.124

8.  The impact of past vaccination coverage and immunity on pertussis resurgence.

Authors:  Matthieu Domenech de Cellès; Felicia M G Magpantay; Aaron A King; Pejman Rohani
Journal:  Sci Transl Med       Date:  2018-03-28       Impact factor: 17.956

9.  Vaccine-driven virulence evolution: consequences of unbalanced reductions in mortality and transmission and implications for pertussis vaccines.

Authors:  Ian F Miller; C Jessica Metcalf
Journal:  J R Soc Interface       Date:  2019-12-11       Impact factor: 4.118

10.  Using age-stratified incidence data to examine the transmission consequences of pertussis vaccination.

Authors:  J C Blackwood; D A T Cummings; S Iamsirithaworn; P Rohani
Journal:  Epidemics       Date:  2016-03-19       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.